{"entity":{"id":"relit-biosciences","kind":"company","name":"Relit Biosciences","aka":[],"tldr":"Relit Biosciences gives patients access to biomarker-based imaging and radioligand therapy, the pairing of a diagnostic scan with a matched radioactive drug.","summary":"Relit Biosciences describes itself as a patient's access point to biomarker-based imaging and radiotherapeutics: theranostic scans that show whether a tumour carries a target such as PSMA or somatostatin receptors, and the radioligand therapies that follow. It is an Even One Ventures portfolio company; its public site is a single page with a contact address.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://relit.bio/"},{"label":"Even One Ventures portfolio","url":"https://evenone.ventures/"}],"tags":["startup","evenone-portfolio","oncology"],"related":[],"cancers":[],"sections":[],"technologies":["radioligand-therapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"United States (head office not published)","country":"US","companyType":"radiopharma","website":"https://relit.bio/","stage":"startup","investors":["evenone-ventures"],"funding":[]},"route":"/companies/relit-biosciences/","neighbours":{"technology":[{"id":"radioligand-therapy","kind":"technology","name":"Radioligand therapy (beta emitters)","route":"/technologies/radioligand-therapy/"}],"company":[{"id":"evenone-ventures","kind":"company","name":"Even One Ventures","route":"/companies/evenone-ventures/"}]}}